
Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy
Author(s) -
Tatsuya Fujino,
Yoko Aoyagi,
Mariko Takahashi,
Ryoko Yada,
Naoko Yamamoto,
Yuki Ohishi,
Akihiko Nishiura,
Motoyuki Kohjima,
Tsuyoshi Yoshimoto,
Kunitaka Fukuizumi,
Mitsuyoshi Nakashima,
Masaki Kato,
Kazuhiro Kotoh,
Makoto Nakamuta,
Munechika Enjoji
Publication year - 2013
Publication title -
world journal of gastrointestinal pharmacology and therapeutics
Language(s) - English
Resource type - Journals
ISSN - 2150-5349
DOI - 10.4292/wjgpt.v4.i3.54
Subject(s) - itpa , ribavirin , medicine , genotype , gastroenterology , pegylated interferon , interleukin 28b , immunology , biology , hepatitis c virus , virus , genetics , gene
To analyzed the association between inosine triphosphatase (ITPA) (rs1127354) genotypes and sustained virological response (SVR) rates in peginterferon (Peg-IFN)α + ribavirin (RBV) treatment.